140 related articles for article (PubMed ID: 21449693)
1. Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China.
Wang SB; Li RY; Yu J
Med Mycol; 2011 Nov; 49(8):799-805. PubMed ID: 21449693
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous zygomycosis caused by rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China.
Lu XL; Liu ZH; Shen YN; She XD; Lu GX; Zhan P; Fu MH; Zhang XL; Ge YP; Liu WD
Clin Infect Dis; 2009 Aug; 49(3):e39-43. PubMed ID: 19566442
[TBL] [Abstract][Full Text] [Related]
3. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
4. Rhizomucor variabilis: a rare causative agent of primary cutaneous zygomycosis.
Patil AB; Chandramohan K; Shivaprakash MR; Nadgir SD; Lakshminarayana SA
Indian J Med Microbiol; 2013; 31(3):302-5. PubMed ID: 23883723
[TBL] [Abstract][Full Text] [Related]
5. Heterothallic mating in Mucor irregularis and first isolate of the species outside of Asia.
Schell WA; O'Donnell K; Alspaugh JA
Med Mycol; 2011 Oct; 49(7):714-23. PubMed ID: 21453223
[TBL] [Abstract][Full Text] [Related]
6. Two new species of Mucor from clinical samples.
Alvarez E; Cano J; Stchigel AM; Sutton DA; Fothergill AW; Salas V; Rinaldi MG; Guarro J
Med Mycol; 2011 Jan; 49(1):62-72. PubMed ID: 20662633
[TBL] [Abstract][Full Text] [Related]
7. The environmental source of emerging Apophysomyces variabilis infection in India.
Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A
Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802
[TBL] [Abstract][Full Text] [Related]
8. A Revised Species Concept for Opportunistic
Wagner L; de Hoog S; Alastruey-Izquierdo A; Voigt K; Kurzai O; Walther G
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182532
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes.
Galgóczy L; Lukács G; Nyilasi I; Papp T; Vágvölgyi C
Acta Biol Hung; 2010 Sep; 61(3):356-65. PubMed ID: 20724281
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous mucormycosis caused by Mucor irregularis.
Xia XJ; Shen H; Liu ZH
Clin Exp Dermatol; 2015 Dec; 40(8):875-8. PubMed ID: 25810249
[TBL] [Abstract][Full Text] [Related]
12. Primary renal zygomycosis due to Rhizopus oryzae.
Yu J; Li RY
Med Mycol; 2006 Aug; 44(5):461-6. PubMed ID: 16882613
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous mucormycosis with necrotising fasciitis in a young immunocompetent individual.
Shivananda P; Mahabala C; Kausalya S; Suchitra S; Anand KU
Trop Doct; 2011 Jul; 41(3):183-4. PubMed ID: 21493646
[TBL] [Abstract][Full Text] [Related]
14. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Alastruey-Izquierdo A; Castelli MV; Cuesta I; Monzon A; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2009 Apr; 53(4):1686-9. PubMed ID: 19171801
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification of zygomycetes from culture and experimentally infected tissues.
Schwarz P; Bretagne S; Gantier JC; Garcia-Hermoso D; Lortholary O; Dromer F; Dannaoui E
J Clin Microbiol; 2006 Feb; 44(2):340-9. PubMed ID: 16455881
[TBL] [Abstract][Full Text] [Related]
16. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
[TBL] [Abstract][Full Text] [Related]
18. Identification of Paecilomyces variotii in clinical samples and settings.
Houbraken J; Verweij PE; Rijs AJ; Borman AM; Samson RA
J Clin Microbiol; 2010 Aug; 48(8):2754-61. PubMed ID: 20519470
[TBL] [Abstract][Full Text] [Related]
19. Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India.
Hemashettar BM; Patil RN; O'Donnell K; Chaturvedi V; Ren P; Padhye AA
J Clin Microbiol; 2011 Jun; 49(6):2372-5. PubMed ID: 21508154
[TBL] [Abstract][Full Text] [Related]
20. Primary Cutaneous Mucormycosis Caused by Rhizopus oryzae: A Case Report and Review of Literature.
Rodríguez-Lobato E; Ramírez-Hobak L; Aquino-Matus JE; Ramírez-Hinojosa JP; Lozano-Fernández VH; Xicohtencatl-Cortes J; Hernández-Castro R; Arenas R
Mycopathologia; 2017 Apr; 182(3-4):387-392. PubMed ID: 27807669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
